Natixis
LLY icon

Natixis’s Eli Lilly LLY Stock Holding History

Natixis’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$2K – 1240
2022
Q3 		$2K Sell
7
-5
-42% -$1.58K ﹤0.01% 1046
2022
Q2 		$4K Buy
+12
New +$3.6K ﹤0.01% 1102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Natixis's LLY Position: Q3 2026 in Review

Natixis reduced its Eli Lilly (LLY) stake by 69% in Q3 2026, selling an estimated $109M and leaving 41,149 shares worth $47.6M. The position accounts for 0.17% of the portfolio, ranked #82.

Natixis first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $267M in Q1 2025. 3,248 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Natixis held 41,149 shares of Eli Lilly worth $47.6M as of Q3 2026.
  • Natixis sold 92,292 Eli Lilly shares in Q3 2026, an estimated $109M.
  • Eli Lilly made up 0.17% of Natixis's portfolio in Q3 2026, its #82 holding.
  • Natixis first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
  • Natixis's Eli Lilly position peaked at $267M in Q1 2025.
  • 3,248 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.